FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q46661236> ?p ?o ?g. }

• Q46661236 description "2014 nî lūn-bûn" @default.
• Q46661236 description "2014年の論文" @default.
• Q46661236 description "2014年学术文章" @default.
• Q46661236 description "2014年学术文章" @default.
• Q46661236 description "2014年学术文章" @default.
• Q46661236 description "2014年学术文章" @default.
• Q46661236 description "2014年学术文章" @default.
• Q46661236 description "2014年學術文章" @default.
• Q46661236 description "2014年學術文章" @default.
• Q46661236 description "2014年學術文章" @default.
• Q46661236 description "2014年學術文章" @default.
• Q46661236 description "2014年學術文章" @default.
• Q46661236 description "2014年學術文章" @default.
• Q46661236 description "2014년 논문" @default.
• Q46661236 description "article científic" @default.
• Q46661236 description "article scientific" @default.
• Q46661236 description "article scientifique (publié 2014)" @default.
• Q46661236 description "articol științific" @default.
• Q46661236 description "articolo scientifico" @default.
• Q46661236 description "artigo científico (publicado na 2014)" @default.
• Q46661236 description "artigo científico (publicado na 2014)" @default.
• Q46661236 description "artigo científico" @default.
• Q46661236 description "artikull shkencor" @default.
• Q46661236 description "artikulong pang-agham" @default.
• Q46661236 description "artykuł naukowy" @default.
• Q46661236 description "artículo científico publicado en 2014" @default.
• Q46661236 description "artículu científicu" @default.
• Q46661236 description "bilimsel makale" @default.
• Q46661236 description "bài báo khoa học" @default.
• Q46661236 description "mokslinis straipsnis" @default.
• Q46661236 description "naučni članak" @default.
• Q46661236 description "scienca artikolo" @default.
• Q46661236 description "scientific article" @default.
• Q46661236 description "teaduslik artikkel" @default.
• Q46661236 description "tieteellinen artikkeli" @default.
• Q46661236 description "tudományos cikk" @default.
• Q46661236 description "vedecký článok" @default.
• Q46661236 description "vetenskaplig artikel" @default.
• Q46661236 description "videnskabelig artikel (udgivet 2014)" @default.
• Q46661236 description "vitenskapelig artikkel" @default.
• Q46661236 description "vitskapeleg artikkel" @default.
• Q46661236 description "vědecký článek" @default.
• Q46661236 description "wetenschappelijk artikel" @default.
• Q46661236 description "wissenschaftlicher Artikel" @default.
• Q46661236 description "επιστημονικό άρθρο" @default.
• Q46661236 description "мақолаи илмӣ" @default.
• Q46661236 description "мақолаи илмӣ" @default.
• Q46661236 description "наукова стаття, опублікована у вересні 2014" @default.
• Q46661236 description "научна статия" @default.
• Q46661236 description "научная статья" @default.
• Q46661236 description "научни чланак" @default.
• Q46661236 description "научни чланак" @default.
• Q46661236 description "գիտական հոդված" @default.
• Q46661236 description "מאמר מדעי" @default.
• Q46661236 description "سائنسی مضمون" @default.
• Q46661236 description "مقالة علمية" @default.
• Q46661236 description "مقالهٔ علمی" @default.
• Q46661236 description "২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q46661236 description "บทความทางวิทยาศาสตร์" @default.
• Q46661236 description "სამეცნიერო სტატია" @default.
• Q46661236 name "P17.04RANO CRITERIA APPLIED TO A PHASE II RANDOMIZED, MULTICENTER TRIAL COMPARING TEMOZOLOMIDE (TMZ) VS TMZ-PLUS-BEVACIZUMAB (BEV) BEFORE STANDARD TREATMENT IN UNRESECTABLE GLIOBLASTOMA (GBM) PATIENTS (P).GENOM 009 STUDY BY THE GEINO GROUP." @default.
• Q46661236 name "P17.04RANO CRITERIA APPLIED TO A PHASE II RANDOMIZED, MULTICENTER TRIAL COMPARING TEMOZOLOMIDE (TMZ) VS TMZ-PLUS-BEVACIZUMAB (BEV) BEFORE STANDARD TREATMENT IN UNRESECTABLE GLIOBLASTOMA (GBM) PATIENTS (P).GENOM 009 STUDY BY THE GEINO GROUP." @default.
• Q46661236 type Item @default.
• Q46661236 label "P17.04RANO CRITERIA APPLIED TO A PHASE II RANDOMIZED, MULTICENTER TRIAL COMPARING TEMOZOLOMIDE (TMZ) VS TMZ-PLUS-BEVACIZUMAB (BEV) BEFORE STANDARD TREATMENT IN UNRESECTABLE GLIOBLASTOMA (GBM) PATIENTS (P).GENOM 009 STUDY BY THE GEINO GROUP." @default.
• Q46661236 label "P17.04RANO CRITERIA APPLIED TO A PHASE II RANDOMIZED, MULTICENTER TRIAL COMPARING TEMOZOLOMIDE (TMZ) VS TMZ-PLUS-BEVACIZUMAB (BEV) BEFORE STANDARD TREATMENT IN UNRESECTABLE GLIOBLASTOMA (GBM) PATIENTS (P).GENOM 009 STUDY BY THE GEINO GROUP." @default.
• Q46661236 prefLabel "P17.04RANO CRITERIA APPLIED TO A PHASE II RANDOMIZED, MULTICENTER TRIAL COMPARING TEMOZOLOMIDE (TMZ) VS TMZ-PLUS-BEVACIZUMAB (BEV) BEFORE STANDARD TREATMENT IN UNRESECTABLE GLIOBLASTOMA (GBM) PATIENTS (P).GENOM 009 STUDY BY THE GEINO GROUP." @default.
• Q46661236 prefLabel "P17.04RANO CRITERIA APPLIED TO A PHASE II RANDOMIZED, MULTICENTER TRIAL COMPARING TEMOZOLOMIDE (TMZ) VS TMZ-PLUS-BEVACIZUMAB (BEV) BEFORE STANDARD TREATMENT IN UNRESECTABLE GLIOBLASTOMA (GBM) PATIENTS (P).GENOM 009 STUDY BY THE GEINO GROUP." @default.
• Q46661236 P1433 Q46661236-107508EF-26AC-4599-A23B-B43A906A8F14 @default.
• Q46661236 P1476 Q46661236-4D7758EB-DE33-480D-A05C-C66362452913 @default.
• Q46661236 P2093 Q46661236-19BABAF3-62E9-4353-B786-CB1FE3CE1DDC @default.
• Q46661236 P2093 Q46661236-1EDB9175-31D6-469E-91CF-E49014E77CCE @default.
• Q46661236 P2093 Q46661236-24D52FDA-C481-4D04-A238-4CA9B3877F19 @default.
• Q46661236 P2093 Q46661236-67BBB453-54F6-4C2A-9031-19414115B86A @default.
• Q46661236 P2093 Q46661236-8919EED8-48A6-4A00-AB1A-9638B6AFC20B @default.
• Q46661236 P2093 Q46661236-8A65843F-8228-446C-A755-975B71205F95 @default.
• Q46661236 P2093 Q46661236-C2689434-0C14-4643-A778-7E2B05DE5C4F @default.
• Q46661236 P2093 Q46661236-DE22E6F9-7EE9-4958-A10D-5EF6DEA9681F @default.
• Q46661236 P304 Q46661236-46A0DA5C-3D59-442F-9024-90EBA3BEBD48 @default.
• Q46661236 P31 Q46661236-B9841081-64CC-430B-B62A-32D858240514 @default.
• Q46661236 P356 Q46661236-993FDD09-D1AA-4511-9AAE-21FFDB1B3324 @default.
• Q46661236 P433 Q46661236-B7241C2A-D200-4BB4-8A05-576B9AB6D450 @default.
• Q46661236 P478 Q46661236-C9C05D1D-DCC4-4020-A8A3-57F0B77F947D @default.
• Q46661236 P50 Q46661236-85CC8FC8-54D7-48D0-BD88-EC076C08DB70 @default.
• Q46661236 P50 Q46661236-BC1BA4EA-E6D5-40E4-8399-E530E97BA255 @default.
• Q46661236 P577 Q46661236-95F52A1D-C94E-4DE0-9B0D-2435CB79B432 @default.
• Q46661236 P921 Q46661236-060DA124-20EB-4243-A5DD-1FBD45A52805 @default.
• Q46661236 P921 Q46661236-675C7172-19FB-4546-BF64-652C2B95A641 @default.
• Q46661236 P921 Q46661236-975AA71B-D419-4501-9BC9-9B0E60E61AAC @default.
• Q46661236 P921 Q46661236-FD20ADBA-4F62-4FC9-B24B-0B05E91EC6DF @default.
• Q46661236 P932 Q46661236-5E182DDE-833B-4639-9765-0AF274A8505B @default.
• Q46661236 P356 NOU174.334 @default.
• Q46661236 P1433 Q15724471 @default.
• Q46661236 P1476 "P17.04RANO CRITERIA APPLIED TO A PHASE II RANDOMIZED, MULTICENTER TRIAL COMPARING TEMOZOLOMIDE (TMZ) VS TMZ-PLUS-BEVACIZUMAB (BEV) BEFORE STANDARD TREATMENT IN UNRESECTABLE GLIOBLASTOMA (GBM) PATIENTS (P).GENOM 009 STUDY BY THE GEINO GROUP" @default.
• Q46661236 P2093 "A. Berrocal" @default.
• Q46661236 P2093 "A. Herrero" @default.
• Q46661236 P2093 "J. Sepúlveda" @default.
• Q46661236 P2093 "M. Gil Gil" @default.
• Q46661236 P2093 "O. Gallego" @default.
• Q46661236 P2093 "P. Perez-Segura" @default.
• Q46661236 P2093 "R. Luque" @default.

• next